HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,818 | -85.9% | 40,600 | -84.2% | 0.00% | -100.0% |
| Q2 2023 | $297,432 | -11.1% | 256,407 | +15.8% | 0.00% | -25.0% |
| Q1 2023 | $334,382 | -23.0% | 221,445 | +27.4% | 0.00% | -20.0% |
| Q4 2022 | $434,488 | -47.7% | 173,795 | -11.7% | 0.01% | -54.5% |
| Q3 2022 | $830,000 | +36.3% | 196,777 | -9.9% | 0.01% | +37.5% |
| Q2 2022 | $609,000 | -52.1% | 218,318 | -1.7% | 0.01% | -42.9% |
| Q1 2022 | $1,271,000 | -31.6% | 222,142 | +9.2% | 0.01% | -30.0% |
| Q4 2021 | $1,858,000 | +1.8% | 203,462 | +19.2% | 0.02% | -4.8% |
| Q3 2021 | $1,825,000 | -29.9% | 170,702 | +1.8% | 0.02% | -32.3% |
| Q2 2021 | $2,602,000 | +30.7% | 167,676 | +36.5% | 0.03% | +24.0% |
| Q1 2021 | $1,991,000 | +6.4% | 122,797 | +38.8% | 0.02% | -13.8% |
| Q4 2020 | $1,872,000 | +57.0% | 88,461 | +10.0% | 0.03% | +38.1% |
| Q3 2020 | $1,192,000 | +2.9% | 80,429 | +2.2% | 0.02% | -4.5% |
| Q2 2020 | $1,158,000 | +208.8% | 78,719 | +146.3% | 0.02% | +214.3% |
| Q1 2020 | $375,000 | +18650.0% | 31,967 | +31867.0% | 0.01% | – |
| Q4 2015 | $2,000 | -86.7% | 100 | -80.0% | 0.00% | – |
| Q2 2015 | $15,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |